NK Alloreactivity Evaluation According to KIR ‐ HLA Interaction Models Influences the Outcome of Haploidentical Haematopoietic Stem‐Cell Transplantation Based on Post‐Transplant Cyclophosphamide
HLA · 2025
DOI: 10.1111/tan.70340 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2025. Verfasst von Jairo Eduardo Niño-Ramírez und 20 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain. Hauptthemen laut MEDLINE: Cyclophosphamide, Hematopoietic Stem Cell Transplantation, Graft vs Host Disease, Killer Cells, Natural. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Fundación por el Desarrollo de la Hematología y Hemoterapia de Salamanca, Gerencia Regional de Salud de Castilla y León.
Abstract (Originalsprache)
Haploidentical haematopoietic stem‐cell transplantation (haplo‐HSCT) is characterised by a high degree of HLA mismatching. Therefore, NK alloreactivity driven by the interactions between KIR and HLA mismatched molecules could benefit its outcome. However, the influence of NK alloreactivity in haplo‐HSCT with post‐transplant Cyclophosphamide (PTCy) remains controversial. The aim of this work was to investigate the clinical utility of predicting NK alloreactivity according to previously described models in the context of haplo‐HSCT with PTCy. We studied 145 patients who underwent this procedure, evaluating the influence of NK alloreactivity in transplant outcomes. Models that disregard the interactions between KIR and HLA evidenced an unsuccessful prediction of the outcomes. On the contrary, approaches based on KIR‐HLA interaction were the most accurate to predict transplant outcomes. The analysis of inhibitory KIRs (iKIRs) based on the missing‐ligand model showed that the presence of at least two iKIR mismatches (iKIRmm) among the donor‐recipient pair was an independent risk factor for acute graft‐versus‐host disease (aGvHD) grade III‑IV (HR: 3.21, p = 0.021), relapse rate (HR: 2.46, p = 0.046), relapse‐free survival (RFS) (HR: 1.96, p = 0.039) and GvHD/relapse‐free survival (GRFS) (HR = 2.16, p = 0.008). The analysis of the missing‐licensing model showed that the existence of the mismatch KIR2DL1/C2 associated to relapse rate (HR: 4.34, p = 0.002) and more than one iKIRmm correlated to poorer RFS (HR: 2.31, p = 0.038) and GRFS (HR: 2.26, p = 0.022). These results suggest that NK alloreactivity influences the outcome of haplo‐HSCT with PTCy and should be incorporated into the donor selection algorithm for this procedure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain.
- Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
- Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
- Centro de Investigación del Cáncer (CIC), Salamanca, Spain.
- Centre de Transfusió de la Comunitat Valenciana, Valencia, Spain.
- Unidad de Inmunología, Departamento de Análisis Clínicos, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
ORCID-Profile: Jairo Eduardo Niño-Ramírez, Francisco Javier Gil-Etayo, Juan López-Pérez, Isabel Jiménez Hernaz, Ariadna Vicente Parra, Pilar Terradillos Sánchez, Nuria Calzada, Francisco Boix, Luis Marín, Daniel Arroyo-Sánchez, Sara Marcos Asensio, Fermín Sánchez-Guijo, Ramón García-Sanz, Amalia Tejeda Velarde
Förderung
- Fundación por el Desarrollo de la Hematología y Hemoterapia de Salamanca
- Gerencia Regional de Salud de Castilla y León
Zitieren
APA
Niño-Ramírez, J. E., Gil-Etayo, F. J., Fonseca-Santos, M., López-Pérez, J., Jiménez Hernaz, I., Vicente Parra, A., Terradillos Sánchez, P., Calzada, N., Boix, F., Marín, L., Arroyo-Sánchez, D., Alcoceba, M., Navarro-Bailón, A., Peña-Muñoz, F., Marcos Asensio, S., Pérez-López, E., Vázquez, L., Sánchez-Guijo, F., García-Sanz, R., …, & Tejeda Velarde, A. (2025). NK Alloreactivity Evaluation According to KIR ‐ HLA Interaction Models Influences the Outcome of Haploidentical Haematopoietic Stem‐Cell Transplantation Based on Post‐Transplant Cyclophosphamide. HLA. https://doi.org/10.1111/tan.70340
Vancouver
Niño-Ramírez JE, Gil-Etayo FJ, Fonseca-Santos M, López-Pérez J, Jiménez Hernaz I, Vicente Parra A, et al. NK Alloreactivity Evaluation According to KIR ‐ HLA Interaction Models Influences the Outcome of Haploidentical Haematopoietic Stem‐Cell Transplantation Based on Post‐Transplant Cyclophosphamide. HLA. 2025. doi:10.1111/tan.70340
BibTeX
@article{NioRamrez2025,
author = {Niño-Ramírez, Jairo Eduardo and Gil-Etayo, Francisco Javier and Fonseca-Santos, Marta and López-Pérez, Juan and Jiménez Hernaz, Isabel and Vicente Parra, Ariadna and Terradillos Sánchez, Pilar and Calzada, Nuria and Boix, Francisco and Marín, Luis and Arroyo-Sánchez, Daniel and Alcoceba, Miguel and Navarro-Bailón, Almudena and Peña-Muñoz, Felipe and Marcos Asensio, Sara and Pérez-López, Estefanía and Vázquez, Lourdes and Sánchez-Guijo, Fermín and García-Sanz, Ramón and López-Corral, Lucía and Tejeda Velarde, Amalia},
title = {NK Alloreactivity Evaluation According to KIR ‐ HLA Interaction Models Influences the Outcome of Haploidentical Haematopoietic Stem‐Cell Transplantation Based on Post‐Transplant Cyclophosphamide},
journal = {HLA},
year = {2025},
doi = {10.1111/tan.70340}
}
EUVIMED